Clinical Operations – Phase II–IV
Clinical Trial Management
Global trials, run tight — interventional and observational.
End-to-end management of Phase II–IV studies across 29 countries and a global investigator network.
What’s included
- Feasibility, site identification & activation across a 2,000+ site network
- Project & medical monitoring; risk-based monitoring and inspection-readiness
- Adaptive designs for drugs and biologics; multi-centric global trials
- Regulatory medical writing (Protocol, IB, CRF, ICF); EC/IRB approvals, amendments, annual reports
Why CEBIS
Deep therapeutic breadth — oncology-haematology, gastroenterology, immunology, rheumatology, nephrology, neurology/CNS, infectious & rare disease, cell & gene therapy, paediatrics and more — delivered with fast recruitment and >95% retention, and priced under a shared-risk model that keeps us accountable for the outcome.